Patient outcomes after fibrinolytic therapy for acute myocardial infarction at hospitals with and without coronary revascularization capability

Journal of the American College of Cardiology

Volumn 40, Issue 6, 2002, Pages 1034-1040

  Mehta, Rajendra H ^a,d   Criger, Douglas A ^b   Granger, Christopher B ^b   Pieper, Karen K ^b   Califf, Robert M ^b   Topol, Eric J ^c   Bates, Eric R ^a  

^a UNIVERSITY OF MICHIGAN   (United States)

^b DUKE CLINICAL RESEARCH INSTITUTE   (United States)

^c LERNER RESEARCH INSTITUTE   (United States)

^d VA ANN ARBOR HEALTHCARE SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ALTEPLASE; ATENOLOL; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIGITALIS; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HEPARIN; INOTROPIC AGENT; NITRATE; STREPTOKINASE;

ACUTE HEART INFARCTION; ADULT; AGED; ANGIOGRAPHY; ANGIOPLASTY; ARTICLE; CLINICAL TRIAL; CORONARY ARTERY BYPASS GRAFT; FEMALE; FIBRINOLYSIS; HEART CATHETERIZATION; HEART MUSCLE REVASCULARIZATION; HOSPITAL; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; TREATMENT OUTCOME;

AGED; CARDIOLOGY SERVICE, HOSPITAL; FEMALE; FIBRINOLYTIC AGENTS; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; MYOCARDIAL REVASCULARIZATION; OUTCOME ASSESSMENT (HEALTH CARE); PATIENT TRANSFER; RETROSPECTIVE STUDIES; STREPTOKINASE; SURVIVAL RATE; THROMBOLYTIC THERAPY; TISSUE PLASMINOGEN ACTIVATOR;

EID: 0037130741     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0735-1097(02)02067-3     Document Type: Article

References (44)

1. Severity-adjusted mortality and length of stay in teaching and non-teaching hospitals
2. Do "America's Best Hospitals" perform better for acute myocardial infarction
3. Effects of admission to a teaching hospital on the cost and quality of care for Medicare beneficiaries
4. The association between hospital volume and survival after acute myocardial infarction in elderly patients
5. Relationship of hospital teaching status with quality of care and mortality for Medicare patients with acute MI
6. Comparison of primary coronary angioplasty and intravenous thrombolytic therapy for acute myocardial infarction: A quantitative review
7. A comparison of management patterns after acute myocardial infarction in Canada and the United States
8. Does more intensive treatment of acute myocardial infarction in the elderly reduce mortality? Analysis using instrumental variables
9. Use of cardiac procedures and outcomes in elderly patients with myocardial infarction in the United States and Canada
10. Use of medical resources and quality of life after acute myocardial infarction in Canada and the United States
11. An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction
12. The effects of tissue plasminogen activator, streptokinase, or both on coronary-artery patency, ventricular function, and survival after acute myocardial infarction
13. Predictors of 30-day mortality in the era of reperfusion for acute myocardial infarction. Results from an international trial of 41,021 patients
14. The association between on-site cardiac catheterization facilities and the use of coronary angiography after acute myocardial infarction
15. Treatment and outcome of myocardial infarction in hospitals with and without invasive capability
16. Thrombolysis In Myocardial Infarction (TIMI) phase II trial: Outcome comparison of a "conservative strategy" in community versus tertiary hospitals
17. Long-term outcome in acute myocardial infarction patients admitted to hospitals with and without on-site cardiac catheterization facilities
18. Six-month outcome in patients with myocardial infarction initially admitted to tertiary and nontertiary hospitals
19. Availability of on-site catheterization and clinical outcomes in patients receiving fibrinolysis for ST-elevation myocardial infarction
20. High-technology cardiac procedures: The impact of service availability on service use in New York State
21. Determinants of the use of coronary angiography and revascularization after thrombolysis for acute myocardial infarction
22. Knowledge and practices of generalist and specialist physicians regarding drug therapy for acute myocardial infarction
23. Outcome of acute myocardial infarction according to the specialty of the admitting physician
24. Patients treated by cardiologists have a lower in-hospital mortality for acute mortality infarction
25. The volume of primary angioplasty procedures and survival after acute myocardial infarction
26. Trends in the use of pharmacotherapies for acute myocardial infarction among physicians who design and/or implement randomized trials versus physicians in routine clinical practice: The MILIS-TIMI experience
27. Mortality within 24 hours of thrombolysis for myocardial infarction: The importance of early reperfusion
28. Variation in the use of cardiac procedures after acute myocardial infarction
29. Regional variation across the United States in the management of acute myocardial infarction
30. A comparison of immediate coronary angioplasty with intravenous streptokinase in acute myocardial infarction
31. A comparison of immediate angioplasty with thrombolytic therapy for acute myocardial infarction
32. Clinical experience with primary percutaneous transluminal coronary angioplasty compared with alteplase (recombinant tissue-type plasminogen activator) in patients with acute myocardial infarction
33. Relationship of symptom-onset-to-balloon time and door-to-balloon time with mortality in patients undergoing angioplasty for acute myocardial infarction
34. A clinical trial comparing primary coronary angioplasty with tissue plasminogen activator for acute myocardial infarction
35. Influence of treatment delay on infarct size and clinical outcome in patients with acute myocardial infarction treated with primary angioplasty
36. Relationship between delay in performing direct coronary angioplasty and early clinical outcome in patients with acute myocardial infarction
37. A randomized trial of thrombolysis vs. transfer for primary PTCA in high risk AMI patients: Results of the AIR PAMI trial
38. A comparison of reteplase with alteplase for acute myocardial infarction
39. Single-bolus tenecteplase compared with front-loaded alteplase in acute myocardial infarction: The ASSENT-2 double-blind randomised trial
40. Reperfusion therapy for acute myocardial infarction with fibrinolytic therapy or combination of reduced fibrinolytic therapy and platelet glycoprotein IIbIIIa inhibition: The GUSTO V randomized trial
41. Efficacy and safety of tenecteplase in combination with enoxaparin, abciximab, or unfractionated heparin: The ASSENT-3 randomized trial in acute myocardial infarction
42. Coronary angioplasty with or without stent implantation for acute myocardial infarction
43. Comparison of angioplasty with stenting, with or without abciximab, in acute myocardial infarction
44. Early revascularization in acute myocardial infarction complicated by cardiogenic shock